Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 87,721 $ 58,910
Marketable securities, current 10,234 0
Prepaid expenses 2,244 1,485
Accounts receivable from related party 240 0
Other current assets 4,424 19
Total current assets 104,863 60,414
Property and equipment, net 6,851 1,952
In-process research and development 26,623 26,623
Other assets 1,821 1,402
Total assets 140,158 90,391
Current liabilities:    
Accounts payable 780 2,517
Accrued liabilities 5,357 2,690
Current portion of long-term debt 0 2,400
Deferred revenue, current 26,231 2,765
Other current liabilities 141 70
Total current liabilities 32,509 10,442
Warrant liabilities 3 954
Deferred revenue, long-term 2,670 0
Long-term debt, net 3,254 1,078
Other liabilities 816 628
Total liabilities 39,252 13,102
Commitments and contingencies (Note 10)
Stockholders’ equity:    
Common stock, $0.001 par value: Authorized: 150,000,000 shares at December 31, 2018 and 2017; Issued and outstanding: 36,736,012 and 26,898,330 shares at December 31, 2018 and 2017, respectively. 37 27
Additional paid-in capital 195,573 141,733
Accumulated other comprehensive loss 0 0
Accumulated deficit (94,704) (64,471)
Total stockholders’ equity 100,906 77,289
Total liabilities and stockholders’ equity $ 140,158 $ 90,391